Trials / Completed
CompletedNCT01203540
Evaluation of the Effect and Tolerance of Preservative Free NAAGA on the Inflammatory Component and Symptoms of Dry Eye Syndrome in Allergic Conjunctivitis Patients
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 21 (estimated)
- Sponsor
- Laboratoires Thea · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
Multicentre, Double blind, Randomized, Comparative Study(comparing N-acetyl-aspartyl-glutamic acid(NAAGA) in Abak preservative free device versus SALINE in Abak preservative free device. Evaluation of the effects and safety of NAABAK® through inflammation markers and symptoms in patients with allergic conjunctivitis and dry eye syndrome after 3 months treatment. The patients will attend 4 visits.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NAABAK eyedrops | |
| DRUG | Saline eyedrops |
Timeline
- Start date
- 2010-10-01
- Completion
- 2011-01-01
- First posted
- 2010-09-16
- Last updated
- 2012-01-31
Locations
2 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01203540. Inclusion in this directory is not an endorsement.